Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 3 2001
A CAPITOL HILL LUNCH & BRIEFING:BIOTECHNOLOGY'S IMPACT ON DISEASES OF THE ELDERLY FRIDAY, MAY 4, 2001 - 562 DIRKSEN SENATE OFFICE BUILDING WASHINGTON, D.C...
Apr 26 2001
WASHINGTON, D.C. (April 26, 2001)The BiotechnologyIndustry Organization (BIO) today announced three headlining speakers for BIO 2001 in San Diego. Two...
Apr 16 2001
TIRED OF THE SAME OLD EARTH DAY STORIES? To: Environment and Earth Science Reporters Contact: Brent Erickson or Peper Long Biotechnology Industry Organization...
Apr 5 2001
MEMORANDUM April 5, 2001 TO: Editors and reporters covering biotechnology FROM: Dan Eramian, Vice President Communications RE: Cloning The issue of cloning is...
Apr 4 2001
WASHINGTON, D.C. (April 4, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry organization (BIO), today issued the following statement to all...
Mar 27 2001
Washington, D.C. (March 27, 2001) –The Energy and Commerce Subcommittee on Oversight and Investigations will hold a hearing on issues raised by the prospect of...
Mar 23 2001
“BIO AsiaPacific”April 18-19, 2001Sheraton Waikiki, Honolulu, Hawaii WASHINGTON, D.C. (March 23, 2001) – The Biotechnology Industry Organization (BIO) today...
Mar 23 2001
(WASHINGTON, D.C.) March 23, 2001 -- Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) issued the following statement on the...
Mar 22 2001
The Biotechnology Industry Organization ("BIO") is pleased to have the opportunity to submit testimony expressing our concerns about the federal...


Biotechnology News

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive’s research wins award at international research symposium Second Quarter (1 Apr. 2014 – 30 Jun. 2014) -- Net...

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: CEO’s comments: "We have achieved strong profitability for the first half of the year with an operating margin of 29...

August 20, 2014

NOTTINGHAM, England--(BUSINESS WIRE)--Source BioScience plc (LSE:SBS) the international laboratory services and products business publishes its Half Year Report for the...

August 20, 2014

BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen Group plc the specialty global pharmaceutical company today announces the acquisition of the global rights to the...

August 19, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix (Nasdaq: OCUL) IPO underwriters exercised in full their over-allotment option to purchase an additional 750,000 shares...